Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation

A Nichols1, M Camps, C Gillieron

  • 1Serono Pharmaceutical Research Institute, Ares-Serono International SA, Plan-les-Ouates 1228, Geneva, Switzerland.

Insights

Mitogen-activated protein kinase phosphatase-3 (MKP-3) inactivates extracellular signal-regulated kinase (ERK) through specific binding. The COOH-terminal lobe of ERK, comprising subdomains V-XI, is crucial for this interaction and phosphatase activation.

Area of Science:

  • Molecular Biology
  • Enzymology
  • Signal Transduction

Background:

  • Mitogen-activated protein kinase phosphatase-3 (MKP-3) is a key enzyme regulating extracellular signal-regulated kinase (ERK) activity.
  • MKP-3 deactivates ERK through specific binding and subsequent dephosphorylation.

Purpose of the Study:

  • To identify the specific domains within ERK essential for binding and catalytic activation by MKP-3.
  • To elucidate the structural basis of the interaction between ERK and MKP-3.

Main Methods:

  • Utilized p38/ERK chimeric molecules to map functional domains.
  • Investigated the role of specific ERK subdomains (V-XI) in MKP-3 interaction.
  • Analyzed the effect of substrate-mimicking peptides and MKP-3 mutations on phosphatase activation.

Main Results:

  • ERK kinase subdomains V-XI were identified as necessary and sufficient for MKP-3 binding and activation.
  • These domains form the major COOH-terminal structural lobe of ERK.
  • Chimeric ERK molecules containing these domains showed enhanced sensitivity to MKP-3 inactivation.
  • Overlap was observed between ERK domains interacting with MKP-3 and those conferring substrate specificity.
  • Peptides from target substrates (Elk-1, p90rsk) and mutations in MKP-3's kinase interaction motif (KIM) inhibited ERK-dependent activation.

Conclusions:

  • The COOH-terminal structural lobe of ERK (subdomains V-XI) is critical for specific recognition and activation of MKP-3.
  • The interaction interface for MKP-3 involves residues within ERK's COOH-terminal lobe and potentially MKP-3's NH2-terminal KIM.
  • Understanding these interactions provides insights into MAP kinase regulation and substrate specificity.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...